GSK Sues Lupin Over ANDA For HIV Drug Combivir

Law360, New York (September 2, 2008, 12:00 AM EDT) -- GlaxoSmithKline PLC is suing Lupin Pharmaceuticals Inc. for its efforts to market a generic version of Combivir, a combination drug used to treat HIV patients.

In a complaint filed Friday in the U.S. District Court for the District of Delaware, the pharmaceutical giant claimed Lupin's abbreviated new drug application with the U.S. Food and Drug Administration infringed GSK's patent.

Lupin notified GSK on July 17 that it had submitted an application to make a product containing 150 mg of lamivudine and 300 mg of zidovudine, the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.